The recently released PREDMETH study results indicate that methotrexate can be considered a real alternative to prednisone for patients with pulmonary sarcoidosis.
Search results for: osteoporosis
Doc Reflects on Rheumatology’s Progress During Past 50 Years
Alan. H. Mallace, MD, FACR, looks back at a half-century of practicing rheumatology & looks ahead to what the future might hold for fellows starting out today.
The Great Pediatric Debate—Corticosteroids in SLE: Slay or Stay?
Long-term use of corticosteroids is associated with numerous adverse effects, particularly in children, but guidance is lacking on how to manage low-dose prednisone in clinically quiescent disease. In The Great Debate at ACR Convergence 2025—Corticosteroids in Pediatric SLE: Slay or Stay, two pediatric lupus experts took to the stage to explore this important topic.
Extra Services Can Boost a Rheumatology Practice’s Profitability, Patient Care
Rheumatology practices can combat declining reimbursements with ancillary services. Experts discuss adding infusion, ultrasound & research services to boost revenue & patient care.
8 Tips for Hiring and Keeping the Best Employees for Your Practice
Even if you hire human resources professionals, as a private practice owner, you still want to have a good grip on the basics of attracting great people to your practice and keeping them happy. Speakers at ACR Convergence 2025 shared pearls to help practice owners do just that.
Complicated Cases Discussed in Pediatric Thieves Market
At this ACR Convergence 2025 session, clinicians discussed complex and difficult-to-diagnose pediatric cases.
Complementary Medicine Meets Rheumatology: New Ways to Reduce Inflammation
At this ACR Convergence 2025 session, the speaker highlighted ways complementary and alternative medicine can be used alongside traditional medical treatments.
3 AC&R Study Summaries: RA & Frailty, Hydroxychloroquine Can Protect Kidneys in Lupus Nephritis, & PT for Knee OA
Research on PT for knee OA, HCQ’s protective role in lupus nephritis & the link between RA disease activity & frailty.
What’s New in Psoriatic Arthritis?
Dr. David Pisetsky curated the research presented at ACR Convergence 2025 and answers the question “What new research on psoriatic arthritis has the potential to impact patient care or future research?”
FDA Approves 2 More Denosumab Biosimilars
The FDA as approved the biosimilar treatments denosumab-nxxp (Bildyos) and denosumab-nxxp (Bilprevda) for all indications of denosumab, their reference product, including osteoporosis in postmenopausal women.
- « Previous Page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- …
- 59
- Next Page »